MediSix Therapeutics' Series A Round

MediSix Therapeutics raised a round of funding on May 15, 2018.

MediSix Therapeutics is a Singapore-based immune engineering company developing novel cellular therapies to address T cell malignancies. …

Articles about MediSix Therapeutics' Series A Round: